191 related articles for article (PubMed ID: 349929)
1. [Spironolactone-induced changes of the renin-angiotensin-aldosterone system and blood pressure lowering in essential hypertension].
Furrer J; Vetter W; Nussberger J; Beckerhoff R; Siegenthaler W
Verh Dtsch Ges Kreislaufforsch; 1977; 43():235-6. PubMed ID: 349929
[No Abstract] [Full Text] [Related]
2. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
Espiner EA; Mansfield H; Miles K
N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
[No Abstract] [Full Text] [Related]
3. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
Mahmud A; Feely J
Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
[TBL] [Abstract][Full Text] [Related]
4. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
5. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
6. [Acute and chronic beta-receptor blockade: influence on blood pressure and on the renin-angiotensin-aldosterone system in essential hypertension].
Stumpe KO; Kolloch R; Gramann W; Vetter H; Krück F
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1325-8. PubMed ID: 1029991
[No Abstract] [Full Text] [Related]
7. [Evaluation of the plasma renin activity and urinary aldosterone excretion in patients with essential hypertension treated with spironolactone. Note II].
Bompiani GD; Scaduto P; Galluzzo A; Donatelli M; Morici ML; Mangano MT; Messina L
Minerva Cardioangiol; 1976 May; 24(5):352-9. PubMed ID: 1012481
[No Abstract] [Full Text] [Related]
8. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
9. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
10. [Effects of acute sodium depletion on blood pressure and renin-angiotensin-aldosterone system in patients with benign essential hypertension (author's transl)].
Kumamoto K
Fukuoka Igaku Zasshi; 1977 Aug; 68(8):397-414. PubMed ID: 914228
[No Abstract] [Full Text] [Related]
11. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
Kreeft JH; Larochelle P; Ogilvie RI
Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
[TBL] [Abstract][Full Text] [Related]
12. Effect of an angiotensin II analogue upon blood pressure, plasma renin concentration and plasma aldosterone in hypertensive patients.
Vierhapper H; Waldhäusl W
Arzneimittelforschung; 1979; 29(8):1175-7. PubMed ID: 583019
[TBL] [Abstract][Full Text] [Related]
13. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
14. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
[TBL] [Abstract][Full Text] [Related]
15. [Renin-angiotensin-aldosterone system in diabetes, arterial hypertension and orthostatic hypotension].
Khristov V; Maleeva A; Turkolev N
Vutr Boles; 1980; 19(4):28-31. PubMed ID: 6998133
[No Abstract] [Full Text] [Related]
16. Editorial: New knowledge of benign essential hypertension.
Laidlaw JC
Can Med Assoc J; 1973 Sep; 109(6):453 passim. PubMed ID: 4355134
[No Abstract] [Full Text] [Related]
17. [Clinical importance of the renin-angiotensin-aldosterone system in hypertension].
Rosenthal J
Med Monatsschr; 1975 Sep; 29(9):387-92. PubMed ID: 1186597
[No Abstract] [Full Text] [Related]
18. [Essential hypertension and the renin-angiotensin-aldosterone system].
Kokot F
Kardiol Pol; 1975; 18(3):209-18. PubMed ID: 1142580
[No Abstract] [Full Text] [Related]
19. Captopril versus enalapril: a comparison of 24 h humoral and hypotensive effects.
Cottone S; Grasso L; D'Ignoto G; Contorno A; Ziletti T; Carapelle E; Carone MB; Fulantelli MA; Cerasola G
Boll Soc Ital Biol Sper; 1987 Sep; 63(9):803-10. PubMed ID: 2833914
[No Abstract] [Full Text] [Related]
20. [Treatment of essential hypertension with spironolactone with reference to the plasma renin activity].
Esch I; Placheta P
Wien Klin Wochenschr; 1973 Jun; 85(23):413-7. PubMed ID: 4575841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
